Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (VGSCs) are transmembrane proteins responsible for the rapid influx of sodium ions into excitable cells, such as neurons, in response to changes in membrane potential. This process is essential for the initiation and propagation of action potentials. The core functional unit is the alpha subunit, composed of four homologous domains (I–IV), each containing six transmembrane segments (S1–S6). The S4 segment acts as the voltage sensor, and the P-loops between S5 and S6 segments form the ion-selective pore. VGSCs are major drug targets, with local anesthetics and antiepileptics blocking these channels.
Channel blockers that prevent sodium ion influx, stabilizing inactive states of the channel and/or accessing binding sites within the pore during depolarization events.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-Gated Sodium Channel (Neuronal) (VGSC).